Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded
- Contract number
- SPE2DX26F6WTH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,967
Award facts
- Contract value 100% obligated
- $5,966.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 17, 2025, for VABYSMO 6 mg/0.05 ml syringes valued at $5,966.88 with a firm fixed-price structure. The delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract with the Defense Logistics Agency. This underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor within the larger $30.3 billion PPV-G GEN V acquisition strategy supporting Department of Defense pharmaceutical supply needs.
The delivery order represents a routine pharmaceutical supply fulfillment within DMS Pharmaceutical Group's extensive product portfolio, which encompasses branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals distributed to military healthcare facilities. The performance location is identified as Park Ridge, Illinois, with an ultimate completion date of November 7, 2025. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial contracting activity with the Defense Logistics Agency, leveraging its small business status to compete effectively in government procurement while maintaining consistent performance across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DX26F6WTH?
SPE2DX26F6WTH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 17, 2025.
How much is contract SPE2DX26F6WTH worth?
The government has obligated $5,967 on SPE2DX26F6WTH.
Is contract SPE2DX26F6WTH an order under another contract?
Yes. SPE2DX26F6WTH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX26F6WTH competed?
The extent of competition for SPE2DX26F6WTH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award